BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25445815)

  • 41. Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.
    Robbins PF; El-Gamil M; Li YF; Zeng G; Dudley M; Rosenberg SA
    J Immunol; 2002 Nov; 169(10):6036-47. PubMed ID: 12421991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infiltration of Lynch colorectal cancers by activated immune cells associates with early staging of the primary tumor and absence of lymph node metastases.
    de Miranda NF; Goudkade D; Jordanova ES; Tops CM; Hes FJ; Vasen HF; van Wezel T; Morreau H
    Clin Cancer Res; 2012 Mar; 18(5):1237-45. PubMed ID: 22261803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer.
    Ishigami S; Arigami T; Uenosono Y; Matsumoto M; Okumura H; Uchikado Y; Kita Y; Nishizono Y; Maemura K; Kijima Y; Nakajo A; Owaki T; Ueno S; Hokita S; Natsugoe S
    Cancer Immunol Immunother; 2012 Oct; 61(10):1663-9. PubMed ID: 22374482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intratumoral T-cell infiltrates and MHC class I expression in patients with stage IV melanoma.
    Al-Batran SE; Rafiyan MR; Atmaca A; Neumann A; Karbach J; Bender A; Weidmann E; Altmannsberger HM; Knuth A; Jäger E
    Cancer Res; 2005 May; 65(9):3937-41. PubMed ID: 15867394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy.
    Maby P; Tougeron D; Hamieh M; Mlecnik B; Kora H; Bindea G; Angell HK; Fredriksen T; Elie N; Fauquembergue E; Drouet A; Leprince J; Benichou J; Mauillon J; Le Pessot F; Sesboüé R; Tuech JJ; Sabourin JC; Michel P; Frébourg T; Galon J; Latouche JB
    Cancer Res; 2015 Sep; 75(17):3446-55. PubMed ID: 26060019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.
    Kooi S; Zhang HZ; Patenia R; Edwards CL; Platsoucas CD; Freedman RS
    Cell Immunol; 1996 Dec; 174(2):116-28. PubMed ID: 8954611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
    Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
    J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression.
    Dierssen JW; de Miranda NF; Ferrone S; van Puijenbroek M; Cornelisse CJ; Fleuren GJ; van Wezel T; Morreau H
    BMC Cancer; 2007 Feb; 7():33. PubMed ID: 17316446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer.
    Mo S; Ma X; Li Y; Zhang L; Hou T; Han-Zhang H; Qian J; Cai S; Huang D; Peng J
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32859741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte.
    Nishimura MI; Avichezer D; Custer MC; Lee CS; Chen C; Parkhurst MR; Diamond RA; Robbins PF; Schwartzentruber DJ; Rosenberg SA
    Cancer Res; 1999 Dec; 59(24):6230-8. PubMed ID: 10626817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen.
    Novellino L; Renkvist N; Rini F; Mazzocchi A; Rivoltini L; Greco A; Deho P; Squarcina P; Robbins PF; Parmiani G; Castelli C
    J Immunol; 2003 Jun; 170(12):6363-70. PubMed ID: 12794170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells.
    Liu A; Takahashi M; Toba K; Zheng Z; Hashimoto S; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    Hematol Oncol; 1999 Dec; 17(4):149-60. PubMed ID: 10725870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.
    Kuwahara T; Hazama S; Suzuki N; Yoshida S; Tomochika S; Nakagami Y; Matsui H; Shindo Y; Kanekiyo S; Tokumitsu Y; Iida M; Tsunedomi R; Takeda S; Yoshino S; Okayama N; Suehiro Y; Yamasaki T; Fujita T; Kawakami Y; Ueno T; Nagano H
    Br J Cancer; 2019 Oct; 121(8):659-665. PubMed ID: 31488881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic.
    Phillips SM; Banerjea A; Feakins R; Li SR; Bustin SA; Dorudi S
    Br J Surg; 2004 Apr; 91(4):469-75. PubMed ID: 15048750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain.
    Thompson JA; Dissanayake SK; Ksander BR; Knutson KL; Disis ML; Ostrand-Rosenberg S
    Cancer Res; 2006 Jan; 66(2):1147-54. PubMed ID: 16424052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance of different types of lymphocyte infiltration.
    Takemoto N; Konishi F; Yamashita K; Kojima M; Furukawa T; Miyakura Y; Shitoh K; Nagai H
    Jpn J Clin Oncol; 2004 Feb; 34(2):90-8. PubMed ID: 15067103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression.
    Jimenez P; Cantón J; Concha A; Cabrera T; Fernández M; Real LM; García A; Serrano A; Garrido F; Ruiz-Cabello F
    Cancer Immunol Immunother; 2000 Mar; 48(12):684-90. PubMed ID: 10752476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma.
    Jäger E; Jäger D; Karbach J; Chen YT; Ritter G; Nagata Y; Gnjatic S; Stockert E; Arand M; Old LJ; Knuth A
    J Exp Med; 2000 Feb; 191(4):625-30. PubMed ID: 10684854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.